Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report
Crossref DOI link: https://doi.org/10.1007/s40261-017-0515-2
Published Online: 2017-03-15
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Giusti, Raffaele http://orcid.org/0000-0003-4592-8868
Mazzotta, Marco
Iacono, Daniela
Lauro, Salvatore
Marchetti, Paolo
License valid from 2017-03-15